Purchase Order 75N91019P00129
Award Date
1/24/19
Potential Completion Date
9/13/24
Potential Value
$14K
Federal Agency
National Cancer Institute
Awardee
N-Of-One, Inc.
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), awarded a firm fixed-price purchase order contract to N-Of-One, Inc. for laboratory testing services. The contract, valued at $11,925.00, has an ultimate completion date of September 13, 2024. N-Of-One, Inc. is a self-certified small disadvantaged business that has received four prime federal contract awards from the NCI between 2019 and 2020, with a total potential value of...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $25,000 purchase order to Nanostring Technologies, Inc. for testing services. The firm fixed price contract will be performed in Seattle, Washington over a four month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's biomedical research mission. No subcontractors or set aside designations...
<p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to C S Bio Co., a Minority Owned Business, Subchapter S Corporation, for $18,175.00 in laboratory testing services. The contract has an anticipated completion date of August 31, 2024 and was awarded on April 1, 2024. The services will be performed in Bethesda, Maryland. No set-aside was used for this award.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $16,265 purchase order to Capralogics Inc. for testing services. The firm fixed price contract will be performed in Hardwick, Massachusetts over a three-month period from July 1, 2023 through September 30, 2023. As the intramural research program of the NCI, a component of the NIH focused on cancer research, this contract supports the agency's mission to lead the nation's...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $18,922 firm fixed price purchase order to Baylor College of Medicine for testing services. The contract has a period of performance from November 8, 2023 through January 8, 2024 and will be performed in Houston, Texas. No major subcontractors or set aside designations were indicated. The National Cancer Institute is the federal agency responsible for cancer research within the United...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
The National Cancer Institute (NCI), part of the Department of Health and Human Services, awarded a $244,943 firm fixed-price purchase order contract to the Public Health Institute, a non-profit organization, to conduct the NCI Patterns of Care Study for prostate cancer, ovarian cancer, and small intestines cancer diagnosed in 2021. The contract, which has no set-aside designation, will involve abstracting medical records to describe cancer treatment patterns, compare treatments over time and...
The National Cancer Institute, a component of the Department of Health and Human Services, awarded a $489,805 firm fixed price purchase order to Biofortis, LLC. The contract provides for Biofortis Labmatrix clinical and translational research management software subscriptions, maintenance, and development support services over a base period of performance from August 2021 through August 2022. The original solicitation sought these capabilities on a sole source basis from Biofortis to provide...
<p>The National Cancer Institute, a civilian federal agency, awarded a firm-fixed-price purchase order contract worth $14,500.00 to Labcorp Genetics Inc. for genetic testing services. The contract has an ultimate completion date of October 31, 2025 and was awarded on April 30, 2025. This contract award is not associated with a larger contract vehicle and does not have a set-aside designation.</p>
<p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>